CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-29 | BVF PARTNERS L P/IL 10% owner | Purchase · Pre-funded Warrants to Purchase Common Stock | +2,213,816 | $3.65 | $8.1M | 7,415,596 |
| 2024-10-29 | BVF PARTNERS L P/IL 10% owner | Purchase · Pre-funded Warrants to Purchase Common Stock | +2,100,244 | $3.65 | $7.7M | 6,235,545 |
| 2024-10-29 | BVF PARTNERS L P/IL 10% owner | Purchase · Pre-funded Warrants to Purchase Common Stock | +440,489 | $3.65 | $1.6M | 838,507 |
| 2024-06-13 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +517,454 | 517,454 | ||
| 2024-06-13 | Little Paul Sean Chief Financial Officer | Grant or award · Stock Option (right to buy) | +267,470 | 267,470 | ||
| 2024-06-13 | Perrin Steven President | Grant or award · Stock Option (right to buy) | +428,148 | 428,148 | ||
| 2024-06-13 | Smith Bryan E. General Counsel, Corporate Sec | Grant or award · Stock Option (right to buy) | +241,650 | 241,650 | ||
| 2024-05-09 | BVF PARTNERS L P/IL 10% owner | Purchase | +1,031,385 | 3,361,803 | ||
| 2024-05-09 | BVF PARTNERS L P/IL 10% owner | Purchase | +821,121 | 2,633,679 | ||
| 2024-05-09 | BVF PARTNERS L P/IL 10% owner | Purchase | +75,431 | 220,460 | ||
| 2024-05-09 | BVF PARTNERS L P/IL 10% owner | Purchase · Pre-funded Warrants to Purchase Common Stock | +3,173,135 | 3,173,135 | ||
| 2024-05-09 | BVF PARTNERS L P/IL 10% owner | Purchase · Pre-funded Warrants to Purchase Common Stock | +2,526,238 | 2,526,238 | ||
| 2024-05-09 | BVF PARTNERS L P/IL 10% owner | Purchase · Pre-funded Warrants to Purchase Common Stock | +232,068 | 232,068 | ||
| 2023-10-02 | Robinson James A. Jr. Director | Grant or award · Stock Option (Right to Buy) | +150,437 | $1.55 | $233K | 150,437 |
| 2023-10-02 | Kirk Allan Director | Grant or award · Stock Option (Right to Buy) | +150,437 | $1.55 | $233K | 150,437 |
| 2023-05-05 | BVF PARTNERS L P/IL 10% owner | Purchase | +1,055,445 | 2,330,418 | ||
| 2023-05-05 | BVF PARTNERS L P/IL 10% owner | Purchase | +837,146 | 1,812,558 | ||
| 2023-05-05 | BVF PARTNERS L P/IL 10% owner | Purchase | +86,341 | 145,029 | ||
| 2023-05-05 | BVF PARTNERS L P/IL 10% owner | Purchase · Pre-funded Warrants to Purchase Common Stock | +2,028,645 | 2,028,645 | ||
| 2023-05-05 | BVF PARTNERS L P/IL 10% owner | Purchase · Pre-funded Warrants to Purchase Common Stock | +1,609,063 | 1,609,063 |
Page 3 of 15 · 300 trades